Navigation Links
Nouveau Life Pharmaceuticals (NOUV) Releases Krill Oil to Support Healthy Cholesterol Levels and Reduce Inflammation
Date:7/31/2012

FORT LAUDERDALE, Fla., July 31, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals Inc. (OTC Pink: NOUV), a provider of quality all-natural dietary supplements, announced today the release of the newest product in the Company's New Life Naturals™ product line: For Your Health – Krill Oil™.

The For Your Health – Krill Oil™ supplement boosts good cholesterol[1] and reduces inflammation[2]. Dr. Oz touted Krill Oil's benefits in November of 2011 saying, "studies have found that Krill Oil works as effectively as omega-3s from other sources, yet at a much lower dose. Furthermore, Krill Oil has been found to raise our good HDL cholesterol and lower our triglycerides as well."

For Your Health – Krill Oil™ was developed by Nouveau Life as part of the Company's focus on health concerns for Baby Boomers and aging adults; however, Krill Oil provides a wealth of benefits to all ages. The oil derived from Krill is rich in phospholipids, the building blocks for cell membranes, and Essential Fatty Acids including Omega-3, 6 and 9.  Krill Oil is commonly used for high triglycerides, heart disease, high blood pressure, rheumatoid arthritis, menstrual pain, ADHD, osteoporosis, hardening of the arteries, kidney problems, and high cholesterol.

New Life Naturals: For Your Health – Krill Oil™ is available for purchase at the Nouveau Life online store at www.nlpnaturals.com. The recommended dose is one to three tablets daily. Every bottle contains 60 softgels, each containing 500 mg of Krill Oil. The supplement retails for $19.99.

About Nouveau Life Pharmaceuticals
The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.

CONTACT:
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993

[1] 2004 Study in the Alternative Medicine Review
[2] 2007 Study in the Journal of the American College of Nutrition


'/>"/>
SOURCE Nouveau Life Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Facelift Alternative by Nouveau Contour
2. Nouveau Life Pharmaceuticals (NOUV) Launches Affiliate Sales Program
3. Nouveau Life Pharmaceuticals (NOUV) In Talks with International Mass Distribution Firms
4. Nouveau Life Pharmaceuticals (NOUV) to Launch Affiliate Sales Program
5. Nouveau Life Pharmaceuticals (NOUV) to Begin Sales of Azul Instant™
6. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
7. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
8. Kinex Pharmaceuticals Receives Substantial Strategic Investment
9. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
10. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
11. Consumers Choosing Organic Alternatives to Traditional Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017  Impax Laboratories, Inc. ... appointed Paul M. Bisaro as Impax,s President ... Company,s Board, effective March 27, 2017. Mr. Bisaro will ... as Interim President and Chief Executive Officer since December ... generic and branded pharmaceutical experience, Mr. Bisaro, 56, is ...
(Date:3/27/2017)... 2017 Invivotek, LLC, a Genesis Biotechnology Group ... pharmacology contract research organization (CRO), announced the completion ... expanded preclinical research facility in Hamilton, New ... renewable energy source to reduce costs and lessen the ... Genesis Solar Farm follows Invivotek,s recent expansion from a ...
(Date:3/24/2017)... , March 24, 2017  Zymo Research ... and Hamilton Robotics, Inc., who designs, manufactures ... ongoing collaboration that teams Zymo Research,s DNA ... and DNA extraction products with Hamilton,s high-throughput ... optimized methods for microbiomics and RNA isolation ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 to 2015, ... for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To combat the ... proposes a tax on prescription opioids to fund drug rehabilitation and prevention services.(3) ...
(Date:3/26/2017)... ... March 26, 2017 , ... ... receive the RealSelf 100 Award, a prestigious award honoring the top influencers on ... to find and connect with doctors and clinics. , In 2016, more than ...
(Date:3/24/2017)... ... March 24, 2017 , ... Clean Earth, Inc., ... and hazardous and non-hazardous materials announced today the acquisition of privately owned ... add four additional processing facilities and a vast array of additional technologies, services, ...
(Date:3/24/2017)... ... March 24, 2017 , ... Infectious disease affects billions of ... United States, it’s a threat that is constantly changing and evolving. Mediaplanet's “Fighting ... offers strategies for the healthcare community to help decrease the number of completely ...
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study by NCPA Senior ... not obey the rules Congress has directed the CBO to follow. The CBO itself ... would restore. Yet, it estimates a reduction in employer-based coverage due to the GOP ...
Breaking Medicine News(10 mins):